Clinical trials: Corneal Endothelial Dysfunction
Fuchs' Endothelial Dystrophy
The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
The purpose of this study is to gain further insights into the molecular pathogenesis of Fuchs' endothelial corneal dystrophy (FECD), to identify targets for potential specific drug therapy.
- Trial name
- NCT01795001
- Testing
- No intervention
- Where
- Belgium
- Volunteers
- 460 people
- Sponsor
- Universitaire Ziekenhuizen KU Leuven